CLASS III Drug recall · Reported 19 Mar 2014 · FDA Enforcement Report

Triamcinolone Acetonide Cream recalled by Fougera Pharmaceuticals

Fougera Pharmaceuticals is recalling Triamcinolone Acetonide Cream USP, 0.1%, distributed nationwide in the US. The recall was initiated on 29 Jan 2014 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15
NDC0168-0002, 0168-0003, 0168-0004
UPC0301680004150, 0301680003153, 0301680002156, 301680004808
Quantity recalled493,192 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1152-2014
FDA event ID
67329
Recalling firm
Fougera Pharmaceuticals, Melville, NY
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Classification
Class III
Status
Terminated
Recall initiated
29 Jan 2014
FDA classified
7 Mar 2014
Reported
19 Mar 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

29 Jan 2014Recall initiated by company
7 Mar 2014Classified by FDA+37 days
19 Mar 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Product as listed by the FDA

Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Which lots are affected?

Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fougera Pharmaceuticals

All 8

Other Triamcinolone Acetonide recalls

All 26